vanadates has been researched along with losartan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akishita, M; Daviet, L; Dzau, VJ; Horiuchi, M; Ito, M; Lehtonen, JY | 1 |
| Burns, KD; Zimpelmann, J | 1 |
2 other study(ies) available for vanadates and losartan
| Article | Year |
|---|---|
Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth.
Topics: Angiotensin II; Animals; Blood Vessels; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Cells, Cultured; Culture Media; DNA; Female; Flavonoids; Gene Expression Regulation, Developmental; Imidazoles; Losartan; Mice; Mice, Knockout; Muscle Development; Muscle, Smooth, Vascular; Okadaic Acid; Phosphoproteins; Phosphorylation; Protein Binding; Pyridines; Receptors, Angiotensin; Vanadates | 1999 |
Angiotensin II AT(2) receptors inhibit growth responses in proximal tubule cells.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Calcium; Cell Division; Cell Line; DNA; Epidermal Growth Factor; Imidazoles; Immunoblotting; Kidney Tubules, Proximal; Losartan; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Protein Tyrosine Phosphatases; Pyridines; Radioligand Assay; Receptors, Angiotensin; Transfection; Vanadates | 2001 |